Zacks Investment Management Arvinas, Inc. Transaction History
Zacks Investment Management
- $11.4 Billion
- Q3 2024
A detailed history of Zacks Investment Management transactions in Arvinas, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 89,827 shares of ARVN stock, worth $2.04 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
89,827
Previous 81,798
9.82%
Holding current value
$2.04 Million
Previous $2.18 Million
1.61%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$159 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$153 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$142 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$87.4 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$63.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.21B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...